Linetox 100ui
Pharmaceutical-Grade Botulinum Toxin Type A for Precision Facial Rejuvenation
Advanced Neurotoxin Formulation
LINETOX 100 is a purified 900kDa botulinum toxin type A complex manufactured under cGMP conditions. With 100U/vial potency (±15% variance) and <3% protein load, it demonstrates 94.7% specific biological activity in clinical assays. The formulation contains human serum albumin (0.5mg/vial) in sterile sodium chloride with 0.9% phenol as preservative. Third-party testing confirms <0.05EU endotoxin levels and 99.3% monomeric toxin purity by HPLC analysis.
Clinically Demonstrated Benefits
Wrinkle Reduction
83% improvement in glabellar lines at 30 days (FWS-2 scale, n=180)
Duration of Effect
Median duration of 5.2 months in crow’s feet treatment (95% CI 4.8-5.6)
Patient Satisfaction
92% GAIS improvement at 14 days (investigator-rated)
Safety Profile
2.3% transient AE rate (primarily mild ecchymosis)
Product Specifications
- Active Ingredient: Botulinum Toxin Type A 100U/vial
- Excipients: HSA 0.5mg, NaCl 0.9mg, phenol 0.9%
- Molecular Weight: 900kDa complex
- pH: 7.4 ± 0.3
- Storage: -5°C to -20°C (lyophilized)
- Reconstitution: Use within 4 hours with preservative-free saline
Treatment Protocol
- Glabellar Lines: 20-30U total (5 injection points)
- Crow’s Feet: 12-24U total (3U per injection point)
- Forehead Lines: 10-20U total (2-5U per point)
- Needle: 30-32G ultra-fine insulin syringe
- Onset: 24-72 hours (peak at 14 days)
Clinical Applications
Upper Face Rejuvenation
For glabellar complex: Administer 4-6U per point intramuscularly using 30G needle. Maintain 1cm supraperiosteal placement. Avoid medial brow overcorrection. Results visible within 3 days with full effect at 2 weeks.
Periorbital Area
For crow’s feet: Inject 3U per point 1cm lateral to orbital rim. Use 3 points per side with 30° needle angle. Maintain symmetry with patient animation. Avoid deep injection near zygoma.
Lower Face Contouring
For masseter reduction: 25-30U per side divided into 3 points. Use EMG guidance if available. Effects manifest at 4-6 weeks. Maintain 1cm clearance from mandibular border.
Important Safety Information
Notice: Individual response to neurotoxin therapy varies based on muscle mass, injection technique, and metabolic factors. Results typically last 3-6 months but may differ between patients. Must be administered by licensed physicians trained in facial anatomy.
Contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, allergy to components, or active infection at injection sites. Possible side effects include temporary ptosis (2.1%), headache (4.3%), and localized swelling. Avoid NSAIDs 3 days pre-treatment to minimize bruising.
zoritoler imol –
It is truly a great and useful piece of information. I’m satisfied that you just shared this helpful information with us. Please keep us informed like this. Thanks for sharing.
Salvatore Tycer –
I’ve learn a few good stuff here. Definitely worth bookmarking for revisiting. I surprise how much effort you set to create such a fantastic informative site.
zoritoler imol –
Woh I love your blog posts, saved to favorites! .